Background: Novel pectin-honey hydrogels have been developed and characterized as medical 26 device. Ideally, a wound dressing should maintain optimal fluid affinity, permit moisture 27 evaporation, protect the wound from microbes, and have shape-conformability, biocompatibility, 28 and antibacterial activity. Objective: A novel, simple and fast method to produce pectin-honey 29 wound dressings is described. Methods: The properties of these pectin-honey hydrogels were 30 investigated, including swelling ability, water vapour transmission rate, hydrogen peroxide 31 production, methylglyoxal content and antibacterial activity. Biocompatibility was assessed by 32 proliferation assays using cultured fibroblast cells and by in vivo study with subcutaneous and 33 intraperitoneal implantation in rats. Results: Hydrogel showed a good water vapour transmission 34 rate, fluid uptake and were not cytotoxic for fibroblasts. The hydrogel demonstrated good 35 antibacterial activity toward clinically relevant pathogens, including S. aureus and E. coli. 36 Biocompatibility was confirmed by the measurement of plasma levels of interleukin (IL)1 beta, 37 IL-6, tumour necrosis factor (TNF) alpha, and prostaglandin (PG)E2. No histological changes 38 were observed. Conclusions: The presence of a natural active component, conformability, and 39 complete resorbability are the main characteristics of this new biocompatible biomaterial that is 40 well tolerated by the body, possibly improves healing, may be used for surgical complications 41 prevention, with a simple and inexpensive production process. 42 43 Keywords: biocompatibility, biomaterial, pectin-honey hydrogels, wound dressing, medical 44 device 45 46 47 48
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Introduction 49
Healing wounds are sites that are easily attacked by bacteria, which leads to the formation of a 50 biofilm that devitalises tissues [1] . The development of a new wound dressing is a focus area for 51 many researchers since the dressing can create a barrier against infection while maintaining a 52 physiological environment in contact with the wound [2-3]. These dressings help to maintain a 53 moist environment at the wound site, promote tissue healing, and reduce infection, pain, and 54 costs [1, [4] [5] . Antimicrobial agents play an important role in reducing bacterial contamination, 55 but the resistance of pathogens to these substances has led to a decrease in the efficacy of 56 antibiotics. Researchers have therefore advised against the use of systemic antimicrobial agents 57 for the treatment of wounds [1, 6] . 58
Various wound dressings consisting of vegetable fibres, protective films, hydrogels, and hydrogel 59 enriched with nitrogen oxides are available commercially [1-2, 5, 7] . Hydrogels are reported to be 60 suitable for use in healing wounds but they have limitations in current use, which include a 61 requirement for high frequency of application, inactivation by wound fluids, and formation of 62 eschars [5] . The requirement for a new antimicrobial substance led to revaluation of ancient 63 remedies, including the use of honey [8] [9] . 64
Honey has been used alone or in combination with other compounds for medical use since 65 ancient times. Honey is a heterogeneous substance, has antimicrobial activity, anti-inflammatory 66 effects and increase the healing process following skin or peritoneal damage [8, 10] . It contains 67 high levels of glycine, methionine and proline which are all fundamental for collagen formation 68 and fibroblast deposition, which are the main factors for wound healing [11] . 69 Manuka honey, produced in New Zealand, is the most studied honey having antibacterial 70
properties against major aerobic and anaerobic bacteria species [12] [13] . 71 4 Several components are known to contribute antibacterial activity of honey. The osmotic effect of 72 the sugars in honey and its characteristically acidic pH are known factors hindering bacterial 73 multiplication. Recently, two components of honey, hydrogen peroxide (H2O2) and 74 methylglyoxal (MGO), have been identified as effective antibacterials [14] [15] [16] . 75
An ideal wound dressing is yet to be developed. Ideally, a wound dressing should maintain 76 optimal fluid affinity, permit moisture evaporation, protect the wound from foreign microbes, and 77 have shape-conformability, biocompatibility, and antibacterial activity [2, [4] [5] 17] . 78
Based on these premises, the aim of the present study was to describe and characterize the 79 properties of pectin-honey hydrogels (PHHs) for wound healing and to assess their 80 biocompatibility through an in vitro and in vivo assay. 81
Material and methods 82

Materials 83
Honey was purchased from Manuka Health (66 Weona Court,Te Awamutu 3800, New Zealand) 84 and pectin from Ardet s.r.l. (Torino, Italy). Culture media, that is, tryptone soy agar (TSA), 85 tryptone soy broth (TSB), peptone water, and 5% sheep blood agar, were purchased from Oxoid 86 (Milan, Italy). Escherichia coli (Turin strain) and Staphylococcus aureus (Turin strain) isolated 87 from canine wounds were used for this work. 88
Preparation of PHHs 89
The preparation method was modified after the procedure described by Walker. (Walker, 1942) 90
[18] Briefly, the pectin-honey hydrogels were prepared starting from a solution (1:1 v/v) of liquid 91 honey (Manuka Health, New Zealand) and sterile deionized water. The same volume of pectin 92 powder (ARDET s.r.l., Italy) was then added and with continuous stirring until the mixture was 93 homogeneous. The resulting gel was spread into 2 mm thick films and hot air dried at 40+/-0.5 94 °C for 6 h. Then it was cut into squares of 5 x 5 cm and further conditioned in an air drier at 25+/-95 5 1 °C for 5 days. The films were then collected and packed in polyethylene under vacuum 96 conditions. All membranes were sterilized by gamma-irradiation at 25 KGray at the Sterigenics 97 Italy (Sterigenics Italy, Minerbio (BO), Italy) [19] . 98
Fluid uptake test (Swelling test) 99
To investigate the fluid swelling ratio of PHHs, samples were cut into disks with a diameter of 100 approximately 25 mm. The dry weights (Wdry) of the membranes were measured and recorded. 101
Afterwards, pre-weighed dry samples were immersed in PBS solution, pH 7.4, at 37°C. The 102 weights of the swollen PHHs were determined every 5 min subsequently by sandwiching the 103 membranes between two paper towels to remove excess water on the surface, and then wet 104 weights (Wwet) were measured. All experiments were performed in triplicate. The swelling 105 ratios were calculated as the average value according to the following formula: 106
Where Ww and Wd represent the weights of wet and dry samples, respectively. 108
Water vapour transmission rate (WVTR) 109
The moisture permeability of the PHH was determined by measuring the WVTR. A piece of the 110 specimen was fixed over the top of a tube (diameter, 34 mm) containing 10 mL PBS. The tube 111 was then placed in an incubator at 37°C and 35% relative humidity. The membranes were 112 weighed at regular intervals of time and the weight loss was recorded and plotted on a graph 113 versus time. The WVTR was calculated from the slope of the graph by the following formula: 114 WVTR g (m2/day) = (slope × 24)/A 115 Where A is area of the sample (m2). Experiments were performed in triplicate. 116
H2O2 analysis 117
The analysis of H2O2 from honey and PHHs was carried out according to the method reported by 118 Long (1999) [20] (ferrous ion oxidation-xylenol orange [FOX] assay), with minor modifications. 119 6 The stock reagents were as follows: reagent 1, 4.4 mM butylated hydroxy toluene (BHT) in 120 HPLC-grade methanol; reagent 2, 1 mM xylenol orange and 2.56 mM ammonium ferrous 121 sulphate in 250 mM H2SO4; working reagent: one volume of reagent 2 added to nine volumes of 122 reagent 1. Approximately 200 mg of honey were diluted with deionized water to the ratio 20% 123 w/w and immediately kept in a thermostat at T = 37 °C, and 100-µL aliquots were added to 900 124 µl of FOX working reagent. After 20 min of incubation at room temperature, absorbance was 125 measured at λ= 560 nm against a blank comprising 900 µL of working reagent and 100-µL 126 aliquots of distilled water (absorbance of diluted honey was negligible at the operative 127 wavelength). H2O2 was monitored at 5, 10, 15, 20, 30, 60, and 120 min and up to 24 and 48 h of 128
incubation. 129
To reduce the processing time required to extract the water-soluble components from PHHs, their 130 size was reduced prior to incubation by cutting the specimens into small pieces with the aid of a 131 small and clean knife. Aliquots of 100 µL of the aqueous layer of the final mixture (40% w/w) 132
were subjected to FOX analysis as described above for honey. Monitoring of H2O2 was carried 133 out at 60 min, 90 min, 24 h, and 48 h. The FOX assay was calibrated using standard H2O2 134 (molar extinction coefficient, 43 M-1 cm-1; absorbance wave length of H2O2 λ = 240 nm; linear 135 range, 0-50 µM). Ten units of catalase were sufficient to destroy all the H2O2 immediately. 136
Controls with catalase were used to exclude interference due to honey constituents. 137
Methylglyoxal (MGO) analysis 138
MGO was evaluated by the method proposed by Wild (2012) [21] with slight modifications. The 139 method is based on the reaction between N-acetyl-L-cysteine (Sigma Aldrich) and MGO at room 140 temperature. Samples were diluted in water (340 mg/ml) and the reaction was performed in 100 141 mM sodium dihydrogen phosphate buffer (adjusted to pH 7.0 with 10 M NaOH) at 22 °C. For the 142 standard curve of the reaction, different concentrations of MGO (0.5, 1, 2, and 5 mM) were used. 143 7 MGO solutions (Sigma Aldrich) equivalent to 0.5, 2, and 5 mM and 10 µl of each honey solution 144 (170 mg HBM/ml water) were added up to a volume of 980 µL with sodium dihydrogen 145 phosphate. The reaction was started by adding 20 µL 500 mM N-acetyl-L-cysteine, and the 146 absorption was recorded after 7 min. The condensation product, N-α-acetyl-S-(1-hydroxy-2-oxo-147
prop-1-yl) cysteine, was determined by recording the absorption at 288 nm (UVIKON 923, Bio-148
Tek Instrument). Results are given in µmol/mg of honey. 149
Protein content analysis of honeys 150
Honey samples were diluted in water and the protein content was determined using the BCA 151 protein assay kit according to the manufacturer's instructions (Pierce, BCA Protein Assay). 152
Microbiological analysis 153
The success of sterilization was verified by the absence of bacterial growth on solid medium (5% 154 sheep blood agar) at 37 °C for 24 h, both in aerobiosis and anaerobiosis. Subsequently 
Results 228
Fluid uptake test (swelling test) 229
The weight of PHHs immersed in PBS solution under physiological mimicking conditions (pH 230 7.4, 37°C). The fluid content increased to about 150% after 180 minutes. The results from the 231 fluid uptake experiment revealed that the dressing has wide capacity to prevent fluid 232 accumulation if used on wound. 233
WVTR 234
The transmission of water vapour through the membranes is an important parameter for the 235 evaluation of their effectiveness as a hydration factor when placed on a wound. The WVTR 236 recommended for wound dressing is 2000-2500 g/m2/day in order to ensure proper wound 237 moisture without risk of dehydration or excessive production of exudates [1, 4] . A good WVTR 238 facilitates the healing process because it improves cell migration and promotes re-239 epithelialization. 240
The water loss from a fully hydrated dressing on exposure to air was evaluated. The mean 241 evaporative water loss from PHHs was 2689.8 ± 158.5 g/m2/day. 242
H2O2-producing activity 243
All the honey samples, before inclusion in the membranes, were able to produce significant 244 amounts of H2O2 while no H2O2 development was observed in the case of corresponding PHHs 245 (data not shown). In Manuka honey, at shorter incubation times up to 90 min of incubation, the 246 concentration of H2O2 generated by honey glucose oxidase was in the range reported in the 247 literature for other types of honey with different methods of analyses (1-2 mM at 30 min of 248 incubation) [16, [25] [26] [27] . By contrast, Manuka honey showed the lowest H2O2production at all 249 incubation times, probably because of its high content of MGO, which has previously been 250 suggested to be a glucose oxidase-inhibitory agent [16, 25] . At longer incubation times (24 and  251 48 h), the tested honey samples displayed a significantly different behaviour: The dramatic loss 252 of H2O2producing activity found for PHHs indicated that their production procedure, which 253 included a heating step at 80 °C and exposure to γ-rays for final sterilization, induced complete 254 loss of glucose oxidase activity. This demonstrated that the preserved antibacterial activity in the 255 microbiological testing was generated solely by the action of nonperoxide agents. 256
MGO analysis 257
Dihydroxyacetone (DHA) is a direct precursor of MG in Manuka honey [15] . The MGO 258 concentration in PHHs, determined by the N-acetyl-L-cysteine assay, was 0.26 ± 0.07 µmol/mg 259 of proteins. The PHHs had higher MG concentration than bulk honey. MGO content is important 12 because it can serve as a suitable quality and cost parameter for Manuka honey. The H2O2 and 261 MG content is responsible for the antibacterial activity of honey [28] and PHHs maintain 262 antibacterial activity similar to that of bulk honey. 263
Microbiological analysis 264
Manuka membranes did not show bacterial contamination after sterilization by gamma-265 irradiation. Table 1 outlines the antibacterial activity based on the clear zone that was produced. 266
In vitro cytotoxicity assay 267
Results concerning the effects induced by different concentrations of dissolved honey membrane 268 on viability of L929 cells are represented in Figure 1 . 269
In vivo biocompatibility study 270
Three rats from the treated group died of ascites in the first 24 hours. The gross evaluation in 36 271 rats showed no wound site infection or presence of adhesions. On performing histological 272 analysis 24 and 72 hours' post-surgery, the tissue near the implant was found to be characterized 273 by the presence of fibroblasts with some cellular response, including lymphocytes, macrophages, 274 and neovascularisation. No reaction was observed in distant organs. Thus, the PHHs did not 275 induce a foreign body reaction. The differences in the blood levels of the IL-1β, IL-6, TNF-α and 276 PG(E2) at the 0, 6, 24, and 72 hours' time points were not statistically significant. The results are 277 summarized in Table 2 . 278
Discussion 279
The new membranes may be used as wound dressings as they have a good WVTR and fluid 280 uptake and show no cytotoxicity to fibroblasts; they also have good swelling capability, which is 281 an important factor for reducing the risk of wound dehydration. PHHs to 1 × 1 cm did not cause any intraperitoneal accumulation of fluid, as determined from 299 macroscopic examination after euthanasia of the remaining rats. The tissue response to 300 intraperitoneal and subcutaneous implants showed a similar macroscopic and histological pattern. 301
In the light of PHHs antibacterial activity [12] and since administration of systemic antibiotics 302 does not always lead to good outcomes in terms of: wound healing, matrix penetration of the EPS 303 biofilm and antibiotic resistance, in this study we propose the use of Manuka honey to prepare 304 PHH for wound dressings. Interestingly, our membranes demonstrate a good antibacterial activity 305 toward clinically relevant pathogenic microorganisms such as S. aureus and E. coli. 306
Honey membranes possess a wide variety of properties that can make them suitable (as for other 307 natural materials such as chitosan hydrogels) [2, 24, 29], for very different uses that we can 308 14 hypothesise ranging from wound healing to adhesion prevention to drug delivery. The presence 309 of natural active components, conformability, and complete resorbability are the main 310 characteristics of this new biocompatible biomaterial that respects the pathophysiology of tissue, 311 is well tolerated by the body, possibly improves healing, and may be used for the prevention of 312 surgical complications. Furthermore, the production of these devices is extremely simple and 313 inexpensive. 314 Table 2 : Results for blood levels of the IL-1β, IL-6, TNF alpha and PG(E2) 399 
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